-
2023
-
Anticancer drugs with fewer side-effects: scientists decode the crystal structure of a key cell cycle protein
-
FDA and Lupus Research Alliance Form Drug Development Consortium
-
EMA Highlights Trial Innovation, Real-World Data Advances
-
Viatris, Cipla and Aurobindo sign up to make generics of GSK’s long-acting HIV PrEP drug
-
EU Approves Amicus Therapeutics Pombiliti for Late-Onset Pompe Disease
-
AstraZeneca, Amgen’s asthma launch Tezspire picks up backing from England’s NICE
-
Cyclerion’s Mitochondrial Diseases Candidate Receives Orphan Drug Designation: Advancing Treatment Options for Patients
-
Glenmark Pharmaceuticals’ Generic of Leo Pharma’s Enstilar Approved
-
Incyte Gets CRL for Jakafi Extended-Release Tablets
-
NICE Recommends Upstaza for Rare Genetic Disorder